Greenwood Capital Associates LLC Increases Stock Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Greenwood Capital Associates LLC boosted its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 5.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 36,938 shares of the construction company’s stock after buying an additional 1,749 shares during the quarter. Greenwood Capital Associates LLC’s holdings in Aspen Aerogels were worth $439,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Lord Abbett & CO. LLC purchased a new stake in shares of Aspen Aerogels during the 3rd quarter valued at approximately $10,126,000. Oppenheimer & Co. Inc. increased its stake in Aspen Aerogels by 167.2% during the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock worth $2,839,000 after acquiring an additional 64,154 shares during the last quarter. Sanders Morris Harris LLC raised its position in Aspen Aerogels by 337.5% in the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock valued at $436,000 after purchasing an additional 27,000 shares during the period. Penserra Capital Management LLC purchased a new stake in Aspen Aerogels in the third quarter valued at $1,342,000. Finally, Geode Capital Management LLC lifted its stake in shares of Aspen Aerogels by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock valued at $38,385,000 after purchasing an additional 75,024 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Barclays cut their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. Roth Mkm reduced their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Canaccord Genuity Group lowered their price objective on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. StockNews.com raised Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. Finally, HC Wainwright restated a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a research report on Wednesday, October 16th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $29.11.

Aspen Aerogels Stock Up 0.1 %

Shares of NYSE ASPN opened at $11.59 on Wednesday. Aspen Aerogels, Inc. has a 12-month low of $10.67 and a 12-month high of $33.15. The stock has a market cap of $950.55 million, a P/E ratio of 1,159.66 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The business’s fifty day simple moving average is $12.75 and its 200-day simple moving average is $19.14.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.